These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparison of health-related quality of life after transarterial chemoembolization and transarterial radioembolization in patients with unresectable hepatocellular carcinoma. Kirchner T; Marquardt S; Werncke T; Kirstein MM; Brunkhorst T; Wacker F; Vogel A; Rodt T Abdom Radiol (NY); 2019 Apr; 44(4):1554-1561. PubMed ID: 30311050 [TBL] [Abstract][Full Text] [Related]
5. Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study. Kwon JH; Kim GM; Han K; Won JY; Kim MD; Lee DY; Lee J; Choi W; Kim YS; Kim DY; Han KH Cardiovasc Intervent Radiol; 2018 Mar; 41(3):459-465. PubMed ID: 29067511 [TBL] [Abstract][Full Text] [Related]
6. The position of transarterial chemoembolization with drug-eluting beads and yttrium-90 transarterial radioembolization in patients with hepatocellular carcinoma: Consensus statements from a Delphi-method expert panel in Turkey. Akarca US; Akhan O; Bilgiç S; Bozkurt MF; Cantaşdemir M; Çermik TF; Çakaloğlu Y; Er Ö; Ilgıt E; Çapa Kaya G; Küçük NÖ; Numan F; Parıldar M; Türkmen C Diagn Interv Radiol; 2021 Nov; 27(6):732-739. PubMed ID: 34792027 [TBL] [Abstract][Full Text] [Related]
7. Transarterial Chemoembolization vs Radioembolization for Neuroendocrine Liver Metastases: A Multi-Institutional Analysis. Egger ME; Armstrong E; Martin RC; Scoggins CR; Philips P; Shah M; Konda B; Dillhoff M; Pawlik TM; Cloyd JM J Am Coll Surg; 2020 Apr; 230(4):363-370. PubMed ID: 32032719 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of transarterial radioembolization versus chemoembolization in patients with hepatocellular carcinoma. Moreno-Luna LE; Yang JD; Sanchez W; Paz-Fumagalli R; Harnois DM; Mettler TA; Gansen DN; de Groen PC; Lazaridis KN; Narayanan Menon KV; Larusso NF; Alberts SR; Gores GJ; Fleming CJ; Slettedahl SW; Harmsen WS; Therneau TM; Wiseman GA; Andrews JC; Roberts LR Cardiovasc Intervent Radiol; 2013 Jun; 36(3):714-23. PubMed ID: 23093355 [TBL] [Abstract][Full Text] [Related]
9. Transarterial strategies for the treatment of unresectable hepatocellular carcinoma: A systematic review. Yang B; Liang J; Qu Z; Yang F; Liao Z; Gou H PLoS One; 2020; 15(2):e0227475. PubMed ID: 32074102 [TBL] [Abstract][Full Text] [Related]
10. Transarterial Chemoembolization and Radioembolization for Unresectable Intrahepatic Cholangiocarcinoma-a Systemic Review and Meta-Analysis. Mosconi C; Solaini L; Vara G; Brandi N; Cappelli A; Modestino F; Cucchetti A; Golfieri R Cardiovasc Intervent Radiol; 2021 May; 44(5):728-738. PubMed ID: 33709272 [TBL] [Abstract][Full Text] [Related]
11. Transarterial Y90 radioembolization versus chemoembolization for patients with hepatocellular carcinoma: A meta-analysis. Zhang Y; Li Y; Ji H; Zhao X; Lu H Biosci Trends; 2015 Oct; 9(5):289-98. PubMed ID: 26559021 [TBL] [Abstract][Full Text] [Related]
12. Comparison of Chemoembolization, Radioembolization, and Transarterial Ethanol Ablation for Huge Hepatocellular Carcinoma (≥ 10 cm) in Tumour Response and Long-Term Survival Outcome. Yu SCH; Hui JW; Li L; Cho CC; Hui EP; Chan SL; Yeo WM Cardiovasc Intervent Radiol; 2022 Feb; 45(2):172-181. PubMed ID: 34604920 [TBL] [Abstract][Full Text] [Related]
13. Liver-dominant Breast Cancer Metastasis: A Comparative Outcomes Study of Chemoembolization Chang J; Charalel R; Noda C; Ramaswamy R; Kim SK; Darcy M; Foltz G; Akinwande O Anticancer Res; 2018 May; 38(5):3063-3068. PubMed ID: 29715141 [TBL] [Abstract][Full Text] [Related]
14. Intra-arterial therapies for unresectable and chemorefractory colorectal cancer liver metastases: a systematic review and meta-analysis. Levy J; Zuckerman J; Garfinkle R; Acuna SA; Touchette J; Vanounou T; Pelletier JS HPB (Oxford); 2018 Oct; 20(10):905-915. PubMed ID: 29887263 [TBL] [Abstract][Full Text] [Related]
15. Regional Therapies for Colorectal Liver Metastases: Systematic Review and Clinical Practice Guideline. Karanicolas P; Beecroft JR; Cosby R; David E; Kalyvas M; Kennedy E; Sapisochin G; Wong R; Zbuk K; Clin Colorectal Cancer; 2021 Mar; 20(1):20-28. PubMed ID: 33257278 [TBL] [Abstract][Full Text] [Related]
16. In intermediate stage hepatocellular carcinoma: radioembolization with yttrium 90 or chemoembolization? El Fouly A; Ertle J; El Dorry A; Shaker MK; Dechêne A; Abdella H; Mueller S; Barakat E; Lauenstein T; Bockisch A; Gerken G; Schlaak JF Liver Int; 2015 Feb; 35(2):627-35. PubMed ID: 25040497 [TBL] [Abstract][Full Text] [Related]
17. Transarterial chemoembolization versus transarterial radioembolization in hepatocellular carcinoma: optimization of selecting treatment modality. Kim DY; Han KH Hepatol Int; 2016 Nov; 10(6):883-892. PubMed ID: 27126821 [TBL] [Abstract][Full Text] [Related]
18. Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis. Tian X; Dai Y; Wang DQ; Zhang L; Sui CG; Meng FD; Jiang SY; Liu YP; Jiang YH Drug Des Devel Ther; 2015; 9():4431-40. PubMed ID: 26309396 [TBL] [Abstract][Full Text] [Related]
19. Meta-analysis: adjusted indirect comparison of drug-eluting bead transarterial chemoembolization versus Ludwig JM; Zhang D; Xing M; Kim HS Eur Radiol; 2017 May; 27(5):2031-2041. PubMed ID: 27562480 [TBL] [Abstract][Full Text] [Related]
20. Intra-Arterial Therapy for Unresectable Colorectal Liver Metastases: A Meta-Analysis. Zhao JJ; Tan E; Sultana R; Syn NL; Da Zhuang K; Leong S; Tai DWM; Too CW J Vasc Interv Radiol; 2021 Nov; 32(11):1536-1545.e38. PubMed ID: 34166803 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]